Jeremy Grantham Surmodics Inc Transaction History

Grantham, Mayo, Van Otterloo & Co. LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2021 May 13, 2021	SELL	$42.18 - $56.07 $919,524 - $1.22 Million	-21,800 Closed	0 $0
Q4 2020 Feb 12, 2021	SELL	$35.18 - $43.52 $474,930 - $587,520	-13,500 Reduced 38.24%	21,800 $949,000
Q3 2020 Nov 13, 2020	BUY	$37.98 - $48.72 $695,034 - $891,576	18,300 Added 107.65%	35,300 $1.37 Million
Q2 2020 Aug 13, 2020	BUY	$31.07 - $44.74 $528,190 - $760,580	17,000 New	17,000 $735,000

141

12.1M

31.4K

13.2K

Ticker SRDX
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 14,005,000
Market Cap $429M
Description
Surmodics, Inc., together with its subsidiaries, provides surface modification technologies for intravascular medical devices, and chemical components for in vitro diagnostic immunoassay tests and microarrays in the United States and internationally. It operates in two segments, Medical Device and In Vitro Diagnostics (IVD). The Medical Device s...

Get notified when there are updates to the investment portfolio of Grantham, Mayo, Van Otterloo & Co. LLC, based on Form 13F filings with the SEC.

Stay updated on Grantham, Mayo, Van Otterloo & Co. LLC and Jeremy Grantham with notifications on news.